Kristina Masson
Board Member
Acrivon Therapeutics, Inc. (ACRV)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Acrivon Therapeutics, Inc. (ACRV) | Ph.D, M.B.A. Executive Vice President, Business Operations, Director | $594,472 | $1,424,926 |
| 2024 | Acrivon Therapeutics, Inc. (ACRV) | M.B.A., Ph.D. Executive Vice President, Business Operations, Director | $565,539 | $1,197,176 |
| 2023 | Acrivon Therapeutics, Inc. (ACRV) | M.B.A., Ph.D. Executive Vice President, Business Operations, Director | $521,383 | $739,783 |
| 2022 | Acrivon Therapeutics, Inc. (ACRV) | M.B.A., Ph.D. Executive Vice President, Business Operations, Director | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.